Decreased interleukin-7 and transforming growth factor-beta1 levels in blister fluids as compared to the respective serum levels in patients with bullous pemphigoid: Opposite behavior of TNF-alpha, Interleukin-4 and Interleukin-10

Experimental Dermatology

Volumn 7, Issue 4, 1998, Pages 157-161

  Giacalone, B ^a   D'Auria, L ^a   Bonifati, C ^a   Ferraro, C ^a   Riccardi, E ^a   Mussi, A ^a   D'Agosto, G ^a   Cordiali Fei, P ^a   Ameglio, F ^a  

^a SAN GALLICANO DERMATOLOGICAL INSTITUTE   (Italy)

Author keywords

Blister fluid; Bullous pemphigoid; IL 4; IL 7; Serum; TGF 1; TNF

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 7; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; BASEMENT MEMBRANE; BLISTER; CLINICAL ARTICLE; CORRELATION FUNCTION; CYTOKINE PRODUCTION; FEMALE; HUMAN; LYMPHOCYTE COUNT; MALE; PEMPHIGOID; PROTEIN DETERMINATION; T LYMPHOCYTE;

EID: 0031656928     PISSN: 09066705     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0625.1998.tb00317.x     Document Type: Article

References (27)

1. Bonifati C, Trento E, Cordiali-Fei P et al. Increased Interleukin-7 concentrations in lesional skin and in the sera of patients with plaque-type psoriasis. Clin Immunol Immunopathol 1997: 83: 41-44.
2. Schmidt E, Bastian B, Dummer R, Tony H P, Brocker E B, Zillikens D. Detection of elevated levels of IL-4, IL-6, and IL-10 in blister fluid of bullous pemphigoid. Arch Dermatol Res 1996: 288: 353-357.
3. Takematsu H, Ohta H, Tagami H. Determination of tumor necrosis factor in blister fluids of bullous pemphigoid. Arch Dermatol Res 1991: 283: 131-132.
4. Tamaki K, So K, Furuya F, Furue M. Cytokine profile of patients with bullous pemphigoid. Br J Dermatol 1994: 130: 128-129.
5. Ameglio F, D'Auria L, Bonifati C et al. Cytokine pattern in blister fluids and serum of patients with bullous pemphigoid; relationships with disease intensity. Br J Dermatol, in press.
6. D'Auria L, Cordiali-Fei P, Pietravalle M et al. The serum levels of sE-selectin are increased in patients with bullous pemphigoid or pemphigus vulgaris. Correlation with the number of skin lesions and recovery after corticosteroid therapy. Br J Dermatol 1997: 137: 59-64.
7. Fazio M, Bonifati C, Ameglio F. La tecnica delle bolle da suzione in dermatologia. G Ital Dermatol Venereol 1994: 129: 467-469.
8. Takashima A, Matsue H, Bergstresser P R, Ariizumi K. Interleukin-7-dependent interaction of dendritic epidermal T-cells with keratinocytes. J Invest Dermatol 1995: Suppl. 1, 50s-53s.
9. Sieling P A, Sakimura L, Uyemura K et al. IL-7 in the cell-mediated immune response to a human pathogen. J Immunol: 1995: 154, 6: 2775-2783.
10. Lever W F, Schaumburg-Lever G. Non infectious vesicular and bullous diseases, in "Histopathology of the skin", 7th Edition, chapter 7, 125-130.
11. Ariizumi K, Meng Y, Bergstresser P R, Takashima A. IFN-gamma-dependent IL-7 gene regulation in keratinocytes. J Immunol 1995: 154: 6031-6039.
12. Lee G, Namen A E, Gillis S, Ellingsworth L R, Kincade P W. Normal B cell precursors responsive to recombinant murine IL-7 and inhibition of IL-7 activity by transforming growth factor-beta. J Immunol 1989: 1: 142(11): 3875-3883.
13. Stotter H, Custer M C, Bolton E S, Guedez L, Lotze M T. IL-7 induces human lymphokine-activated killer cell activity and is regulated by IL-4. J Immunol 1991: 1: 146: 150-155.
14. Sugita Y, Nagatani T, Ikezawa Z et al. Modulation of bullous pemphigoid antigen gene expression by gamma-interferon in cultured keratinocytes. Brit J Dermatol 1992: 126: 468-473.
15. Tamai K, Li K, Silos S et al. Interferon-gamma-mediated inactivation of transcription of the 230-kDa bullous pemphigoid antigen gene (BPAG1) provides novel insight into keratinocyte differentiation. J Biol Chem 1995: 270/1: 392-396.
16. Su H, Reano A, Hesse S, Viac J, Thivolet J. Modulation of bullous pemphigoid antigens by gamma-Interferon in cultured human keratinocytes. J Dermatol 1990: 17: 16-23.
17. Costello R, Imbert J, Olive D. Interleukin-7, a major Tlymphocyte cytokine. Eur Cytokine Netw 1993: 4(4): 253-262.
18. Borger P, Kauffman H F, Postma D S. IL-7 differentially modulates the expression of IFN-gamma and IL-4 in activated Human T lymphocytes by transcriptional and posttranscriptional mechanism. J Immunol 1996: 156: 1333-1338.
19. Naume B. Espevik T. Immunoregulatory effects of cytokines on natural killer cells Scand J Immunol 1994: 40(2): 128-134.
20. Santambrogio L, Hochwald G M, Saxena B. Studies on the mechanism by which transforming growth factor-beta (TGF-beta) protects against allergic encephalomyelitis. Antagonism between TGF-beta and tumor necrosis factor. J Immunol 1993: 151: 1116-1127.
21. 1 on experimental autoimmune diseases in mice. Proc Natl Acad Sci USA 1991: 88: 2918-2821.
22. Dubinett S M, Huang M, Dhanani S, Wang J, Beroiza T. Down-regulation of macrophage transforming growth factor-beta messenger RNA expression by IL-7. J Immunol 1993: 151: 6670-6680.
23. Kupper T S. Role of epidermal cytokines. In: Oppenheim J J, Shevach E M, eds. Immunophysiology. The role of cells and cytokines in immunity and inflammation. New York: Oxford University Press, 1990: 285-305.
24. 2) in normal and transformed human keratinocytes. J Invest Dermatol 1992: 99-4: 409-414.
25. Benjamin D, Sharma V, Knobloch T J et al. Human B cell lines constitutively secrete IL-7 and express IL-7 receptors. J Immunol 1994: 152: 4749-4754.
26. 4 in human B cells. Eur J Immunol 1989: 19: 1311-1315.
27. Tsuda S, Miyasato M, Kasada M et al. Eosinophil-mediated basement membrane zone injury in bullous pemphigoid. J Invest Dermatol 1988: 90: 61.